Skip to main content

Clinical Studies with the Nal-Glu GnRH Antagonist

  • Chapter
  • 50 Accesses

Abstract

Because of the existence of anaphylactoid side effects following the subcutaneous (sc) injection of first generation antagonists of the [D-Arg6] class, there have been few clinical trials using GnRH antagonists in humans. These agents cause mast cell degranulation and histamine release [1, 2]. Recently, new classes of compounds have been designed and are available for phase 1 clinical trials.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morgan, JR, O’Neil, CE, Coy, DH, Hocart, SJ and Nekola, MV (1986). Antagonist analogs of LHRH are mast cell secretagogues. Int Arch Allergy Appl Immunol, 80, 70

    Article  PubMed  CAS  Google Scholar 

  2. Schmidt, F, Sundaram, K, Thau, RB and Bardin, CW (1984). [Ac-D-Nal(2)1, 4-FD-Phe2, D-Trp3, D-Arg6]LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception, 29, 283

    Article  PubMed  CAS  Google Scholar 

  3. Rivier, JE, Porter, J, Rivier, CL, Perrin, M, Hook, WA, Siraganian, RP and Vale, WW. New effective GnRH antagonists with minimal potency for histamine release in vitro. J med Chem, in press

    Google Scholar 

  4. Mais, V, Kazer, RR, Cetel, NS, Rivier, J, Vale, W and Yen, SSC (1986). The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a GnRH antagonist as a probe, J Clin Endocrinol Metab, 62, 1250

    Article  PubMed  CAS  Google Scholar 

  5. Borghi, MR, Niesvisky, R, Balmaceda, JP, Coy, DH, and Schally, AV (1983). Administration of LHRH analogs delays ovulation without affecting the luteal function in rhesus monkeys. Fertil Steril, 40, 678

    PubMed  CAS  Google Scholar 

  6. Fraser, HM (1987). LHRH antagonists and female reproductive function. In: Vickery, BH and Nestor, JJ Jr (eds.) “LHRH and its Analogs: Contraceptive and Therapeutic Applications. Part 2”. p.227. (Lancaster UK: MTP Press)

    Google Scholar 

  7. Hutchison, BS3S and Zeleznik, AJ (1984). The rhesus monkey corpus luteum function is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle. Endocrinology, 115, 1780

    Article  PubMed  CAS  Google Scholar 

  8. Fraser, HM, Baird, DT, McRae, GI, Nestor, JJ, Vickery, BH (1985). Suppression of luteal progesterone secretion in the stumptailed macaque by an antagonist analogue of LHRH. J Endocrinol, 104 R1

    Article  PubMed  CAS  Google Scholar 

  9. Fraser, HM and Baird, DT (1987). Clinical applications of LHRH analogues. J Clin Endocrinol Metab, 1, 43

    CAS  Google Scholar 

  10. Bhasin, S and Swerdloff, RS (1986). Mechanism of GnRH agonist action in the human male. Endocr Rev, 7, 106

    Article  PubMed  CAS  Google Scholar 

  11. Monahan, MW, Rivier, J, Vale, W, Guillemin, R and Burgus, R (1972). [Gly2]LRF and des-His2-LRF. The synthesis, purification, and characterization of two LRH analogues antagonistic to LRF. Biochem Biophys Res Commun, 47, 551

    Article  PubMed  CAS  Google Scholar 

  12. Pavlou SN, Wakefield, GB and Kovacs, WJ (1987). LHRH antagonists in normal men. In: Vickery, BH and Nestor, JJ (eds.) “LHRH and its Analogs: Contraceptive and Therapeutic Applications. Part 2”. p.245. (Lancaster UK: MTP Press)

    Google Scholar 

  13. Dahl, KD, Pavlou, SN, Kovacs, WJ and Hsueh, AJW (1986). The changing ratio of serum bioactive to immunoactive FSH in normal men following treatment with a potent GnRH antagonist. J Clin Endocrinol Metab, 63, 792

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bouchard, P. et al. (1990). Clinical Studies with the Nal-Glu GnRH Antagonist. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0725-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0725-6_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6811-6

  • Online ISBN: 978-94-009-0725-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics